Deal Flow 3.0: European Venture Capital Deal Term Review 2022

JurisdictionEuropean Union
Subject MatterLife Sciences,Startups,IPO,EU,Big Data,Venture Capital,SaaS,Debt Financing,Investment Funds,Emerging Technology Companies,Critical Infrastructure Sectors,Investment,FinTech,Capital Raising
Law FirmOrrick, Herrington & Sutcliffe LLP
AuthorNicola Whiteley,Dr. Sven Greulich, LL.M. , EMBA,Scott Morrison,Katie Cotton,Shawn Atkinson,Chris Grew,Dr. Thomas Schmid,Attilio Mazzilli,Christine Kaniak, LL.M.,Livia Maria Pedroni,Alessandro Vittoria,Flavio Notari,Ylan Steiner,Jamie Moore,Carsten Bernauer,Johannes Rüberg,Faraaz Samadi,Dr. Jörg Ritter,Dr. Christoph Rödter,Benjamin Cichostepski-Lesage,Olivier Vuillod,Raphael Crouan,Kelly Hagedorn,Anna Humphrey,Daniel Jones,Peter Sugden,Christopher Sprado
Published date10 March 2023

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT